local
Allergy medication recall: Cetirizine tablets pulled over contamination risk
Summary by The Houston Editorial Desk · Based on reporting by Chris Williams , FOX 26 Houston
· July 22, 2026
· 1 min read
Unique Pharmaceutical Laboratories is voluntarily recalling four nationwide lots of Cetirizine Hydrochloride Tablets USP 5 mg after discovering the allergy medication may be cross-contaminated with ranitidine, according to the FDA.
Story provenance No corrections
Summary created by The Houston Editorial Desk — automated, rule-governed Original reporting Chris Williams, FOX 26 Houston Original story Read at the source Source published Jul 22, 2026 Indexed here Jul 22, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Why this matters in The Houston
For Houston residents, the recall of Cetirizine Hydrochloride Tablets USP 5 mg is particularly concerning given the city's notorious allergy issues. As a city surrounded by sprawling urban landscapes and waterways, Houston's environment can exacerbate allergy symptoms, making reliable medication a necessity for many. The potential contamination of these tablets with ranitidine, a medication that has been linked to cancer risks in the past, raises serious health concerns for those who rely on Cetirizine to manage their allergies. Residents who take this medication should be vigilant in checking their prescriptions and contacting their pharmacists or healthcare providers to determine if their medication is part of the recalled lots. The Houston Independent School District may also need to take steps to inform parents and staff about the recall, as students and employees may be affected.
About this story
Original reporting by FOX 26 Houston . The Houston surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit FOX 26 Houston . Have a tip or correction? Contact our newsroom .
Category: local ·
Published: July 22, 2026 ·
Source: FOX 26 Houston ·
Reading time: 1 min
Frequently asked about this story
What is this story about? Unique Pharmaceutical Laboratories is voluntarily recalling four nationwide lots of Cetirizine Hydrochloride Tablets USP 5 mg after discovering the allergy medication may be cross-contaminated with ranitidine, according to the FDA.
When was this published? This article was first published on July 22, 2026 by FOX 26 Houston and curated for The Houston readers.
Who reported this story? This story was reported by Chris Williams at FOX 26 Houston. To learn more about how The Houston selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more local coverage from The Houston, or browse our daily briefing and topic hubs .
← Back to all news
More local →
Today’s briefing
Subscribe to newsletter